Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.37 USD | +5.97% | +6.25% | +22.74% |
May. 14 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Cellectar Biosciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cellectar Biosciences, Inc.
Roth MKM | |
Oppenheimer | |
HC Wainwright | |
Maxim |
EPS Revisions
- Stock Market
- Equities
- CLRB Stock
- Consensus Cellectar Biosciences, Inc.